| 產(chǎn)品編號(hào) | D60218 |
| 英文名稱 | TAK-385 |
| 中文名稱 | 瑞盧戈利 |
| 別 名 | RVT-601 |
| 克 隆 號(hào) | |
| CAS | 737789-87-6 |
| 理論分子量 | 623.63 kDa |
| 檢測(cè)分子量 | |
| 保存條件 | 2-8℃ |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Relugolix (TAK-385) is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209). Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al |
